Learn about Pseudomonas infection diagnosis, including clinical documentation, medical coding (ICD-10 codes), and healthcare best practices. Find information on Pseudomonas aeruginosa, antibiotic susceptibility testing, microbiology lab results, and treatment options. This resource covers relevant information for healthcare professionals, clinicians, and medical coders seeking accurate and up-to-date guidance on Pseudomonas infection diagnosis and management.
Also known as
Other bacterial diseases
Covers infections by Pseudomonas, like Pseudomonas aeruginosa.
Other bacterial agents as the cause
Includes Pseudomonas as a cause of diseases classified elsewhere.
Diseases of the respiratory system
May include Pseudomonas infections like pneumonia or bronchitis.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Pseudomonas infection site specified?
Yes
Is it a UTI?
No
Code as A49.8, B96.5 if confirmed as principal
When to use each related code
| Description |
|---|
| Pseudomonas infection |
| Gram-negative bacteremia |
| Sepsis |
Coding Pseudomonas infection without specifying the infection site leads to inaccurate severity and reimbursement.
Lack of proper clinical documentation to support Pseudomonas infection diagnosis can cause audit failures and denials.
Incorrectly coding sepsis due to Pseudomonas or vice-versa can impact quality reporting and reimbursement.
Patient presents with signs and symptoms suggestive of Pseudomonas aeruginosa infection. Presenting complaints include purulent sputum production, fever, chills, and dyspnea consistent with potential pneumonia. Alternatively, the patient may exhibit localized symptoms such as wound infection with green, foul-smelling drainage, otitis externa, or urinary tract infection depending on the site of infection. Relevant medical history includes cystic fibrosis, recent hospitalization, prolonged antibiotic use, or immune compromise, increasing the risk of Pseudomonas infection. Physical examination reveals rales or rhonchi in suspected pulmonary involvement, erythema, edema, and tenderness at the site of localized infection, or other relevant clinical findings. Differential diagnosis includes other bacterial infections such as Klebsiella pneumoniae, Escherichia coli, and Staphylococcus aureus. Preliminary diagnosis of Pseudomonas infection is based on clinical presentation and supported by laboratory findings. Sputum culture, wound culture, urine culture, or blood culture, depending on the site of infection, will be performed to confirm the diagnosis and identify antibiotic susceptibility. Treatment plan includes initiation of empiric antibiotic therapy with antipseudomonal agents such as ceftazidime, cefepime, piperacillin-tazobactam, or carbapenems, considering patient allergies and local resistance patterns. Treatment will be adjusted based on culture and sensitivity results. Patient education regarding medication adherence, infection control measures, and follow-up care will be provided. The patient will be monitored for clinical improvement and potential complications such as sepsis or antibiotic-related adverse effects. ICD-10 codes will be assigned based on the specific site and type of Pseudomonas infection, such as J15.1 for Pseudomonas pneumonia or B96.5 for Pseudomonas as the cause of diseases classified elsewhere. Appropriate CPT codes for diagnostic tests and therapeutic procedures will be documented for billing and coding purposes. Continued monitoring and reassessment will be performed to ensure optimal clinical outcomes and appropriate management of the Pseudomonas infection.